USPSTF: Evidence lacking for cognitive impairment screening

USPSTF: evidence lacking for cognitive impairment screening

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that the evidence is insufficient to assess the balance of benefits and harms of cognitive impairment screening for older adults without signs or symptoms of cognitive impairment. This draft recommendation statement is based on an evidence review published in the Nov. 5 issue of the Annals of Internal Medicine.

Noting that some screening tools have sufficiently high sensitivity and specificity to be clinically useful in identifying dementia, researchers from the USPSTF reviewed the literature to assess the benefits and harms of of all older adults for cognitive impairment. The draft recommendation statement is applicable to adults older than 65 years without signs or symptoms of cognitive impairment.

The researchers found that the evidence was insufficient to evaluate the balance of benefits and harms of cognitive impairment screening. The draft recommendation statement is available for comment from Nov. 5 to Dec. 2, 2013.

"Although the benefits and harms of what we can offer patients through routine screening are unclear right now, clinicians should remain alert to early signs or symptoms of and evaluate their patients as appropriate," Task Force co-vice chair Albert Siu, M.D., M.S.P.H., said in a statement.

More information: Draft Recommendation Statement
Comment on Recommendations
Background Review

add to favorites email to friend print save as pdf

Related Stories

USPSTF: Evidence lacking for cognitive impairment testing

Oct 22, 2013

(HealthDay)—Screening instruments can detect dementia but there is insufficient evidence to determine the clinical effect of screening and interventions, according to a review conducted for the U.S. Preventive Services ...

Recommended for you

Anti-diabetic drug springs new hope for tuberculosis patients

5 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

Chikungunya virus shuts down infected cells

6 hours ago

Researchers from Wageningen University, part of Wageningen UR, in collaboration with colleagues from Leiden University and a research team in Australia, have revealed how chikungunya virus blocks essential ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.